Market Overview
The global metagenomic sequencing market, valued at US$1.8 billion in 2022, stood at US$2.0 billion in 2023 and is projected to advance at a resilient CAGR of 17.5% from 2023 to ...
De novo sequencing service enables the direct determination of protein and antibody primary structures without relying on existing sequence databases. As a core analytical strategy in structural ...
Global metagenomic sequencing market is undergoing rapid expansion as microbiome science, infectious disease surveillance, and precision medicine integrate deeper into clinical and research pipel...
The N-terminal of a protein marks the beginning of its expression and is integral to regulating subcellular localization, degradation, and turnover. MtoZ Biolabs offers high-quality N-terminal ...
MtoZ Biolabs offers state-of-the-art C-terminal sequencing service utilizing LC-MS/MS technology, ensuring high sensitivity and specificity while maintaining compliance with ICH Q6B regulatory ...
